Scientific Advisory Board Hibernaid In the News

Contact us for more information

Stephen J. PettiStephen J. Petti, R.N., BSN, BBA, FAHA
Chief Executive Officer

See expanded bio on Company Management page.

Email him at sjpetti@hibernaid.com

 

Laurence Katz, M.D.Laurence M. Katz, M.D.
Founder, Chief Scientific Officer, Chief Medical/Scientific Director

See expanded bio on Company Management page.

Email him at lkatz@hibernaid.com

 

Ron Tribble, DMDRon Tribble, DMD
Senior Business Advisor to the CEO

See expanded bio on Company Management page.

Email him at rtribble@hibernaid.com

 

Kathryn M. Martin, PharmDKathryn M. Martin, Pharm.D.
Director, Drug Development

Dr. Martin joined Hibernaid in July 2010 with nearly 25 years of experience in clinical trial management and regulatory affairs. She heads up the company's Regulatory Affairs effort, as well as medical writing and scientific communications. Dr. Martin holds a BS in Pharmacy from Northeastern University and a Pharm D from the University of Texas in Austin. She completed residency training in oncology pharmacy practice at the Audie Murphy VA Hospital and was among the first clinical pharmacists in the United States to become certified by the American Society of Health Systems Pharmacists. Kate has experience in a range of areas within pharmaceutical development, including medical writing, regulatory affairs, and IND/NDA/BLA development and filings. This experience includes interpreting clinical and statistical data, writing of clinical and regulatory documents, and development/execution of scientific communication plans. She has previously served as a consultant to Novartis, Amgen, Teva Pharmaceuticals, Wyeth Ayerst and Drais Pharma. She is the founder and president of Glenmere Research in Montebello NY, an independent contract firm specializing in medical writing and regulatory affairs.

Email her at kmmartin@hibernaid.com


Melissa BarronMelisa K. Barron, Ph.D.
Director, Chemistry, Manufacturing and Controls/Formulations Development

Melisa Barron joined Hibernaid in 2012 with over 20 years of industry experience as scientific contributor and management. She heads the Company's CMC and formulations development. Dr. Barron holds a B.S. degree in Chemistry and obtained her Ph.D. in Pharmaceutical Sciences at the University of Texas at Austin specializing in drug delivery of biologics and poorly soluble small molecule therapeutics. Dr. Barron has held key development team and leadership positions at Theravance and Affinium Pharmaceuticals responsible for managing technical consultants and contract manufacturing and research organizations to support non-clinical and Phase I/II/III development of novel, small molecule antibiotics. As senior scientist at Theravance, Dr. Barron was principal to the successful NDA submission and approval for marketing and commercialization of the new drug product, VIBATIV™ (Telavancin®) for Injection in September 2009. She is the author of many research articles in peer reviewed scientific journals and has delivered several presentations at scientific conferences in the US and abroad. Dr. Barron is owner of an independent contract consulting firm providing professional pharmaceutical development consulting services with expertise in drug delivery, manufacture of clinical trial materials and regulatory submissions. As a consultant Dr. Barron recently worked with Achaogen Inc. in development of the new drug product, plazomicin injection and assisted in preparation of the NDA submission in late 2017.

Email her at mkbarron@hibernaid.com


Sydney GilmanSydney Gilman, Ph.D.
Director, Regulatory Affairs

Sydney Gilman joined Hibernaid in 2012. Dr. Gilman is a former FDA Chemistry reviewer who spent 6 years at FDA in various CDER Therapeutic Drug Divisions of the Center for Drug Evaluation and Research with consulting ties to Biologics. Dr. Gilman has 20 years experience in the pharmaceutical industry in positions ranging from Senior Scientist to Director to Vice President responsibilities. He also has spent more than 10 years consulting targeting regulatory strategy, CMC and operations. He earned his Ph.D. in Organic Chemistry from the University of Pittsburgh.

Email him at sgilman@hibernaid.com


Samn RaffanielloSamn Raffaniello
Director, Administration and Project Services

See expanded bio on Company Management page.

Email her at samn@hibernaid.com

 


Patricia PiercePatricia Pierce
Administrative Assistant

Patricia (Trish) Pierce is the newest member of the Hibernaid team and works as Administrative Assistant to the CEO and to the team overall. Trish formerly worked in an administrative role at a veterinary office. She earned her degree from the University of Ph.

Email her at Trish@hibernaid.com